Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.

Authors

• R Jeffrey Karnes
• Vidit Sharma
• Voleak Choeurng
• Hussam Al-Deen Ashab
• Nicholas Erho
• Mohammed Alshalalfa
• Bruce Trock
• Ashley Ross
• Kasra Yousefi
• Harrison Tsai
• Shuang G Zhao
• Jeffrey J Tosoian
• Zaid Haddad
• Mandeep Takhar
• S Laura Chang
• Daniel E Spratt
• Firas Abdollah
• Robert B Jenkins
• Eric A Klein
• Paul L Nguyen
• Adam P Dicker
• Robert B Den
• Elai Davicioni
• Felix Y Feng
• Tamara L Lotan
• Edward M Schaeffer

Publication/Presentation Date

8-15-2018

Volume

24

Issue

16

First Page

3908

Last Page

3916

ISSN

1557-3265

Published In/Presented At

Karnes, R. J., Sharma, V., Choeurng, V., Ashab, H. A., Erho, N., Alshalalfa, M., Trock, B., Ross, A., Yousefi, K., Tsai, H., Zhao, S. G., Tosoian, J. J., Haddad, Z., Takhar, M., Chang, S. L., Spratt, D. E., Abdollah, F., Jenkins, R. B., Klein, E. A., Nguyen, P. L., … Schaeffer, E. M. (2018). Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy. Clinical cancer research : an official journal of the American Association for Cancer Research, 24(16), 3908–3916. https://doi.org/10.1158/1078-0432.CCR-17-2745

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

29760221

Department(s)

Administration and Leadership

Document Type

Article